<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00520338</url>
  </required_header>
  <id_info>
    <org_study_id>Si 117/2007</org_study_id>
    <nct_id>NCT00520338</nct_id>
  </id_info>
  <brief_title>Celecoxib for Reducing Morphine Requirement After Thyroid Surgery: A Randomized Controlled Trial</brief_title>
  <official_title>Celecoxib for Reducing Morphine Requirement After Thyroid Surgery: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether celecoxib is effective in the treatment
      postoperative pain after thyroidectomy.

      The research hypothesis:

      There is a difference in postoperative morphine consumption in the first 24 hours after
      thyroidectomy between patients who received celecoxib or placebo.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Postoperative pain has been concerned in the past few years by both the anesthesiologists ans
      the surgeons. COX2-inhibitors have played an important roles in postoperative pain with
      minimal side effects.

      Comparison(s): There is a difference in postoperative morphine consumption in the first 24
      hours after thyroidectomy between patients who received celecoxib and placebo.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2007</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The patients' total amount of morphine requirement in the first 24 hour.</measure>
    <time_frame>24 hour</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Postoperative Pain</condition>
  <condition>Thyroidectomy</condition>
  <condition>Cyclooxygenase 2 Inhibitors</condition>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo
celecoxib</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>1 placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>celecoxib</intervention_name>
    <description>placebo
celecoxib 400 mg oral single dose</description>
    <arm_group_label>2</arm_group_label>
    <other_name>celebrex</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient ASA physical status I-III.

          2. Scheduled for an elective thyroidectomy.

          3. Body weight &gt; or = 40kg

          4. Can operate a patient-controlled analgesia (PCA) device.

        Exclusion Criteria:

          1. History of asthma, acute rhinitis, nasal polyps, angioneurotic edema or urticaria
             following the administration of aspirin or other NSAIDs.

          2. Known hypersensitivity to morphine or sulfonamides.

          3. History of hepatic dysfunction.

          4. Creatinine clearance &lt; 30ml/min.

          5. History of bleeding tendency.

          6. History of gastrointestinal bleeding or active peptic ulcer.

          7. Known case of inflammatory bowel disease.

          8. Patient with severe heart failure.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sirilak Suksompong, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of anesthesiology. Siriraj Hospital, Mahidol University, Bangkok, Thailand</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anesthesiology, Faculty of Medicine, Siriraj Hospital, Mahidol University</name>
      <address>
        <city>Bangkok</city>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>November 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 22, 2007</study_first_submitted>
  <study_first_submitted_qc>August 23, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 24, 2007</study_first_posted>
  <last_update_submitted>November 6, 2010</last_update_submitted>
  <last_update_submitted_qc>November 6, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 9, 2010</last_update_posted>
  <responsible_party>
    <name_title>Sirilak Suksompong</name_title>
    <organization>Mahidol University</organization>
  </responsible_party>
  <keyword>celecoxib</keyword>
  <keyword>postoperative pain</keyword>
  <keyword>thyroidectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Celecoxib</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

